Exotic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 01-01-2025
- Paid Up Capital ₹ 1.50 M
as on 01-01-2025
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.60 Cr
as on 01-01-2025
About Exotic Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹1.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dharmisthaben Pandya, Jaymit Bakshi, and Shilpica Bakshi serve as directors at the Company.
- CIN/LLPIN
U24231GJ1993PTC019298
- Company No.
019298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1993
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Exotic Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmisthaben Pandya  | Whole-Time Director | 03-Mar-2014 | Current |
| Jaymit Bakshi | Director | 05-Sep-2018 | Current |
| Shilpica Bakshi | Director | 24-Dec-2019 | Current |
Financial Performance of Exotic Laboratories.
Exotic Laboratories Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Exotic Laboratories?
In 2017, Exotic Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apcot Hospitals Private LimitedActive 16 years 4 monthsDharmisthaben Pandya, Jaymit Bakshi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 28 Jul 2009 | ₹8.00 M | Satisfied |
Bank Of Baroda Creation Date: 03 Oct 1994 | ₹8.00 M | Satisfied |
How Many Employees Work at Exotic Laboratories?
Exotic Laboratories has a workforce of 5 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exotic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exotic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
